148 related articles for article (PubMed ID: 28036261)
21. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
22. Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients.
Liu R; Hao S; Zhang H; Ma J; Liu X; Xu J; Liu X; Ning J; Sun Y; Jiang L; Li G; Song X; Zheng H
Oncotarget; 2017 Sep; 8(43):74129-74138. PubMed ID: 29088773
[TBL] [Abstract][Full Text] [Related]
23. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
24. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers.
Milas M; Mazzaglia P; Chia SY; Skugor M; Berber E; Reddy S; Gupta M; Siperstein A
Surgery; 2007 Feb; 141(2):137-46; discussion 146. PubMed ID: 17263967
[TBL] [Abstract][Full Text] [Related]
25. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
27. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
28. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification.
Salvianti F; Giuliani C; Petrone L; Mancini I; Vezzosi V; Pupilli C; Pinzani P
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672797
[TBL] [Abstract][Full Text] [Related]
29. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
30. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
Li D; Butt A; Clarke S; Swaminathana R
Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studies.
Cui Z; Chen Y; Xiao Z; Hu M; Lin Y; Chen Y; Zheng Y
Oncotarget; 2016 May; 7(18):25791-800. PubMed ID: 27015554
[TBL] [Abstract][Full Text] [Related]
32. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of magnifying narrow-band imaging for early gastric cancer: A meta-analysis.
Hu YY; Lian QW; Lin ZH; Zhong J; Xue M; Wang LJ
World J Gastroenterol; 2015 Jul; 21(25):7884-94. PubMed ID: 26167089
[TBL] [Abstract][Full Text] [Related]
34. The potential of circulating exosomal RNA biomarkers in cancer.
Chu YL; Li H; Ng PLA; Kong ST; Zhang H; Lin Y; Tai WCS; Yu ACS; Yim AKY; Tsang HF; Cho WCS; Wong SCC
Expert Rev Mol Diagn; 2020 Jul; 20(7):665-678. PubMed ID: 32188269
[TBL] [Abstract][Full Text] [Related]
35. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
36. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
37. [Transcription and promoter hypermethylation of thyroid stimulating hormone receptor gene in human papillary thyroid carcinoma].
Dai YL; Cai DH; Chen H; Zhang Y; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):114-7. PubMed ID: 20117998
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract][Full Text] [Related]
40. Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
Liang MX; Fei YJ; Yang K; Tang WJ; Cao XH; Tang JH
BMC Cancer; 2022 Sep; 22(1):954. PubMed ID: 36064384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]